Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Day: October 17, 2022
-
By Kevin E. Noonan – On September 28, 2022, the Patent Trial and Appeals Board suspended proceedings in Interference No. 106,126, between junior Party the Broad Institute, Harvard University and MIT (collectively, "Broad") and Senior Party ToolGen, and in Interference No. 106,127, between Junior Party the University of California, the University of Vienna, and Emmanuelle Charpentier…
-
By Donald Zuhn — A number of European firms, including J A Kemp, reported on Friday that the Administrative Council of the European Patent Organisation had passed a change to the rules of the EPC relating to the date on which a document is deemed to be delivered. The change will eliminate the 10-day rule,…
-
IPWatchdog and ClearstoneIP will be offering a webinar entitled "Building a Robust Freedom-to-Operate Process: Finding Competitive Edges & Avoiding Pitfalls" on October 20, 2022 at 12:00 pm (ET). Gene Quinn of IPWatchdog, Inc. will moderate a panel consisting of Matthew Engel of Baker Botts, Ben Vastine of Braskem America, and Gabe Sukman of ClearstoneIP. The…
-
American Conference Institute (ACI) will be holding an International Summit on Biosimilars and Originator Biologics on December 1-2, 2022 at the Hilton Munich Park, Munich Germany, and as a livestreaming event. Co-chairs Sharada F. Devarsetty from Sandoz and Christine Berndt from STADA Arzneimittel AG will host, wherein ACI faculty will offer presentations on the following…
Patent Docs 